Rafferty Asset Management »

Candel Therapeutics shares owned by Rafferty Asset Management

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Rafferty Asset Management from 13F filings

Historical chart of Rafferty Asset Management investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Rafferty Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Rafferty Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $580k 56k 10.30

More positions owned by Rafferty Asset Management

Micron Technology (MU)
NVIDIA Corporation (NVDA)
Advanced Micro Devices (AMD)
Broadcom (AVGO)
Intel Corporation (INTC)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Applied Materials (AMAT)
Kla Corp Com New (KLAC)
Marvell Technology (MRVL)
Lam Research Corp Com New (LRCX)
Ishares Msci Sth Kor Etf (EWY)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Texas Instruments Incorporated (TXN)

View all positions for Rafferty Asset Management

Top funds holding Candel Therapeutics

FMR
Rtw Investments
BlackRock
Acorn Capital Advisors
Portolan Capital Management
Saturn V Capital Management
Vanguard Capital Management
Geode Capital Management
Millennium Management
State Street Corporation
Halter Ferguson Financial
Northern Trust
Kennedy Capital Management
Vanguard Portfolio Management
Vanguard Fiduciary Trust

View all funds holding Candel Therapeutics